Clinical trials
Epilepsy trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 1 |
| 2011 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 8 |
| Cyberonics, Inc. | 2 |
| Norwegian University of Science and Technology | 2 |
| UCB Pharma | 2 |
| Eisai Limited | 1 |
| Haukeland University Hospital | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| King's College London | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 27 |
| Seizures | 5 |
| Epilepsies, Partial | 4 |
| Intellectual Disability | 2 |
| Ataxia | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Autism Spectrum Disorder | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.